Observational studyScientific reports2025
H-Wave device stimulation benefits chronic shoulder pain in an observational cohort study of patient-reported outcome measures.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- H-WaveMedicina (Kaunas, Lithuania) · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patient-reported outcome measures (PROMs) studies for H-Wave device stimulation (HWDS) for chronic low back and neck pain (cLBP, cNP) have been promising, so a retrospective statistical analysis of chronic shoulder pain (cSP) patients was conducted. Surveys from a cohort of 34,192 pain patients, filtered for chronicity of 3-36 months and device use of 22-365 days, resulted in 1496 with "all shoulder" diagnoses, including 772 rotator cuff disorder patients. Reported shoulder pain dropped 3.17 points (0-10 pain scale), with significant (≥ 20%) relief in 89.73%. Reported function/activities of daily living (ADL) improved in 96.40% and work performance in 84.86%. Medications decreased in 74.61% and sleep improved in 59.89%. Over 96% patient satisfaction and no adverse events were reported. Subgroup analyses found benefit with longer device use and shorter pain chronicity, while rotator cuff outcomes were equivalent to all shoulder conditions. Similarly positive outcomes were self-reported by cSP patients as for previously published cLBP and cNP patients, suggesting device appropriateness beyond spinal conditions. HWDS may have contributed to effective cSP relief and improvements in function and ADL, while also improving sleep and work performance. Medication reduction (e.g., opioids) in 3 of 4 shoulder patients was higher than reported for low back and neck conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.